Cargando…
Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease
OBJECTIVE: Proton pump inhibitor (PPI) use has been associated with reduced diversity of the gut microbiome and may lead to worse clinical outcomes in inflammatory bowel disease (IBD). We aimed to evaluate whether PPI use affects clinical outcomes in a real-world setting. DESIGN: Healthcare claims d...
Autores principales: | Choden, Tenzin, Zhang, Hui, Sakuraba, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124315/ https://www.ncbi.nlm.nih.gov/pubmed/37070427 http://dx.doi.org/10.1080/07853890.2023.2198775 |
Ejemplares similares
-
Improving clinical outcomes of Barrett’s esophagus with high dose proton pump inhibitors and cryoablation
por: Snady, Harry
Publicado: (2023) -
Unexplained abdominal pain as a driver for inappropriate therapeutics: an audit on the use of intravenous proton pump inhibitors
por: Lai, Pauline Siew Mei, et al.
Publicado: (2014) -
The prospective multiple-centre randomized controlled clinical study of high-dose amoxicillin-proton pump inhibitor dual therapy for H. pylori infection in Sichuan areas
por: Shen, Cheng, et al.
Publicado: (2022) -
Clinical communication in inflammatory bowel disease: a systematic literature review protocol
por: Karimi, Neda, et al.
Publicado: (2020) -
Is administration of proton pump inhibitors in functional dyspepsia worth the risk of developing gastric cancer: a Markov model to bridge the gap between scientific evidence and clinical practice
por: Broide, Efrat, et al.
Publicado: (2020)